Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Japan”

A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast CancerActive Not Recruiting
NCT06112379Phase 3Updated Jul 13, 2026
Sponsor: AstraZeneca
Breast Cancer
United States, Australia, Austria, Belgium, Brazil +21 more
Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular EventsActive Not Recruiting
NCT05360446Phase 3Updated Jul 13, 2026
Sponsor: Novartis Pharmaceuticals
Coronary Artery Disease
United States, Argentina, Australia, Belgium, Brazil +13 more
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in AdultsRecruiting
NCT07015905Phase 3Updated Jul 13, 2026
Sponsor: Regeneron Pharmaceuticals
Venous Thromboembolism (VTE)
United States, Bulgaria, Hungary, Japan, Latvia +3 more
Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell CarcinomaRecruiting
NCT06490003N/AUpdated Jul 13, 2026
Sponsor: City of Hope Medical Center
Esophageal Squamous Cell Carcinoma · Chemotherapy Effect · DNA Methylation
Japan
Fragility Fractures of the Pelvis (FFP)Active Not Recruiting
NCT04182776N/AUpdated Jul 13, 2026
Sponsor: AO Innovation Translation Center
Pelvic Fracture
United States, Canada, Germany, Hong Kong, Japan +2 more
A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 DiabetesCompleted
NCT05254002Phase 2Updated Jul 13, 2026
Sponsor: Bayer
Type 2 Diabetes Mellitus · Chronic Kidney Disease
United States, Belgium, Canada, Denmark, France +9 more
A Post-Marketing Clinical Trial of Pemafibrate in Patients ｗith Hypercholesterolemia and Inadequate Response to StatinsRecruiting
NCT07634484Phase 4Updated Jul 13, 2026
Sponsor: Kowa Company, Ltd.
Hypercholesterolemia
Japan
Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell CarcinomaRecruiting
NCT06476067N/AUpdated Jul 13, 2026
Sponsor: City of Hope Medical Center
Esophageal Cancer · Recurrence · DNA Methylation
Japan
Study Assessing Long-teRm Outcomes of dupiluMAb (DUPIXENT®) Treatment in Adult Patients With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)Active Not Recruiting
NCT04959448N/AUpdated Jul 13, 2026
Sponsor: Regeneron Pharmaceuticals
Chronic Rhinosinusitis With Nasal Polyposis
United States, Canada, Germany, Italy, Japan +1 more
A Study to Investigate the Effect of AZD5004 on Mitiglinide and Pioglitazone in Healthy ParticipantsCompleted
NCT07444424Phase 1Updated Jul 13, 2026
Sponsor: AstraZeneca
Healthy Participants
Japan
Pembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast CancerRecruiting
NCT06976944Phase 2Updated Jul 13, 2026
Sponsor: Yukinori Ozaki
Recurrent Triple-Negative Breast Cancer
Japan
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative ColitisNot Yet Recruiting
NCT07697456Phase 2Updated Jul 13, 2026
Sponsor: AbbVie
Crohn's Disease · Ulcerative Colitis
United States, Australia, Belgium, Germany, Japan +4 more
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid TumorsRecruiting
NCT06726148Phase 1, Phase 2Updated Jul 13, 2026
Sponsor: Novartis Pharmaceuticals
Advanced HR+/HER2- Breast Cancer · Advanced CCNE1-amplified Solid Tumors · Extensive-stage Small Cell Lung Cancer
United States, Australia, Canada, China, Czechia +11 more
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic LeukemiaRecruiting
NCT07109219Phase 1, Phase 2Updated Jul 13, 2026
Sponsor: AstraZeneca
B-cell Acute Lymphoblastic Leukemia (B-ALL)
United States, Australia, Canada, China, Japan +4 more
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor AntagonistsRecruiting
NCT06033950Phase 3Updated Jul 10, 2026
Sponsor: Colorado Prevention Center
Heart Failure
United States, Argentina, Brazil, Canada, Croatia +9 more
Cardiac Sarcoidosis Randomized TrialRecruiting
NCT03593759Phase 3Updated Jul 10, 2026
Sponsor: Ottawa Heart Institute Research Corporation
Cardiac Sarcoidosis · Sarcoidosis
United States, Canada, Japan, New Zealand, United Kingdom
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DMRecruiting
NCT07667803Phase 3Updated Jul 10, 2026
Sponsor: AstraZeneca
Weight Management
United States, Argentina, Australia, Brazil, Canada +14 more
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) EncephalitisActive Not Recruiting
NCT05503264Phase 3Updated Jul 10, 2026
Sponsor: Hoffmann-La Roche
NMDAR Autoimmune Encephalitis · LGI1 Autoimmune Encephalitis
United States, Argentina, Brazil, China, Czechia +12 more
A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular LymphomaActive Not Recruiting
NCT04712097Phase 3Updated Jul 10, 2026
Sponsor: Hoffmann-La Roche
Relapsed or Refractory Follicular Lymphoma
United States, Australia, Brazil, China, France +10 more
Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory PolyneuropathyCompleted
NCT06568042Phase 2Updated Jul 10, 2026
Sponsor: Eli Lilly and Company
Neuropathic Pain · Distal Sensory Polyneuropathy
United States, Canada, Germany, Japan, Mexico +2 more
A Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES)Active Not Recruiting
NCT04191304Phase 3Updated Jul 10, 2026
Sponsor: AstraZeneca
Hypereosinophilic Syndrome
United States, Argentina, Austria, Belgium, China +12 more
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid TumorsRecruiting
NCT06997029Phase 1Updated Jul 10, 2026
Sponsor: Bristol-Myers Squibb
Advanced Solid Tumor · Advanced Breast Cancer · Advanced Ovarian Cancer
United States, Denmark, Japan
Skeletal Muscle-derived Cell Implantation for Treatment of Fecal IncontinenceRecruiting
NCT04976153Phase 3Updated Jul 10, 2026
Sponsor: Innovacell GmbH
Fecal Incontinence
Austria, Bulgaria, Czechia, France, Germany +7 more
A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007)Terminated
NCT06113328Phase 2Updated Jul 10, 2026
Sponsor: Merck Sharp & Dohme LLC
Non-segmental Vitiligo
United States, Argentina, Australia, Belgium, Canada +13 more
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing TumorsActive Not Recruiting
NCT04482309Phase 2Updated Jul 10, 2026
Sponsor: AstraZeneca
Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer · Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer
United States, Australia, Belgium, Brazil, Canada +12 more

Previous page Next page